The ROE as of November 2025 (TTM) for Opiant Pharmaceuticals, Inc. (OPNT) is 7.31%

According to Opiant Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 7.31%. This represents a change of -124.68% compared to the average of -29.62% of the last 4 quarters.

Opiant Pharmaceuticals, Inc. (OPNT) Historical ROE (quarterly & annually)

How has OPNT ROE performed in the past?

The mean historical ROE of Opiant Pharmaceuticals, Inc. over the last ten years is 316.18%. The current 7.31% ROE has changed -97.69% with respect to the historical average. Over the past ten years (40 quarters), OPNT's ROE was at its highest in in the January 2014 quarter at 297.03%. The ROE was at its lowest in in the October 2017 quarter at -12245.65%.

Opiant Pharmaceuticals, Inc. (OPNT) ROE by Quarter and Year

Discovering the peaks and valleys of Opiant Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Opiant Pharmaceuticals, Inc. (OPNT) Average ROE

How has OPNT ROE performed in the past?

The current ROE of Opiant Pharmaceuticals, Inc. (OPNT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Opiant Pharmaceuticals, Inc. (OPNT) ROE vs. Peers

How is OPNT’s ROE compared to its peers?

Opiant Pharmaceuticals, Inc.’s ROE is greater than Cyteir Therapeutics, Inc. (-26.35%), greater than RVL Pharmaceuticals plc (-80.88%), greater than HilleVax, Inc. (-44.61%), greater than Tourmaline Bio, Inc. (-30.50%), greater than Jounce Therapeutics, Inc. (-25.03%), greater than Miromatrix Medical Inc. (-74.80%), greater than Decibel Therapeutics, Inc. (-56.38%), greater than Graybug Vision, Inc. (-109.10%), less than Paratek Pharmaceuticals, Inc. (42.54%), greater than Aadi Bioscience, Inc. (-8.09%),

Build a custom stock screener for Opiant Pharmaceuticals, Inc. (OPNT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Opiant Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Opiant Pharmaceuticals, Inc. (OPNT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Opiant Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.